Centre Paul Strauss

Futó vizsgálatok

• Toboroz

  Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse

  NCT07871864· 3. fázis· Forrás

• Még nem toboroz

  Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers

  NCT07437287· 2/3. fázis· Forrás

• Még nem toboroz

  Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01)

  NCT07337447· 2. fázis· Forrás

• Toboroz

  Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study

  NCT05653635· 2. fázis· Forrás

• Toboroz

  Irradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and Attention

  NCT06599879· Forrás

• Toboroz

  Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI.

  NCT07195344· 4. fázis· Forrás

• Toboroz

  Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab

  NCT06796114· Forrás

• Toboroz

  Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma

  NCT05653622· 2. fázis· Forrás

• Toboroz

  Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib

  NCT06620835· 2. fázis· Forrás

• Toboroz

  Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer

  NCT06600802· Forrás

• Fut, nem toboroz

  Treatment of microstellite stable metastatic colorectal cancer presenting high immune infiltrate with chemotherapy (XELOX or FOLFOX Bevacizumab) and immunotherapy ( Pembrolizumab)

  NCT04262687· 2. fázis· Forrás

• Toboroz

  Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers

  NCT06425133· 2. fázis· Forrás

• Toboroz

  Superiority Trial Evaluating Digitalized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatment.

  NCT06211257· Forrás

• Toboroz

  A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer

  NCT05639413· Forrás

• Toboroz

  Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC

  NCT05122806· Forrás

• Toboroz

  EULAT Eradicate GBC

  NCT06192719· Forrás

• Toboroz

  High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

  NCT04221035· 3. fázis· Forrás

• Toboroz

  PD-(L)1 iNhibitors with concurrent IRadiation at VAried tumour sites in advanced Non-small cell lung cAncer

  2024-512173-27-00· 3. fázis· Forrás

• Fut, nem toboroz

  Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer

  NCT03408665· Forrás

• Fut, nem toboroz

  PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer

  NCT03774732· 3. fázis· Forrás

• Toboroz

  Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)

  NCT03848052· Forrás

• Fut, nem toboroz

  Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer

  NCT02947685· 3. fázis· Forrás

• Fut, nem toboroz

  Tracking Triple-negative Breast Cancer Evolution Through Therapy

  NCT03077776· Forrás

• Toboroz

  Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008

  NCT03275311· Forrás

• Fut, nem toboroz

  Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer

  NCT02089100· 3. fázis· Forrás

• Fut, nem toboroz

  Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma

  NCT01924819· 2/3. fázis· Forrás

• Fut, nem toboroz

  Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)

  NCT00967863· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák4 toboroz
• Gyermekkori daganatok3 toboroz
• Máj- és epeúti rák3 toboroz
• Áttétes emlőrák2 toboroz
• Glioblasztóma2 toboroz
• Szarkóma2 toboroz
• Vastagbélrák2 toboroz
• Neuroblasztóma1 toboroz
• Neuroendokrin daganatok1 toboroz
• Prosztatarák1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution

  NCT06379880· Forrás

• Lezárult

  Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)

  NCT06525675· Forrás

• Leállították

  Futibatinib in Patients With Specific FGFR Aberrations

  NCT04189445· 2. fázis· Forrás

• Lezárult

  A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies

  NCT04042558· 2. fázis· Forrás

• Lezárult

  Trial evaluating the tolerance and safety of durvalumab - radiotherapy combination for treatment of cancers of the head and neck

  2024-513977-31-00· 2. fázis· Forrás

• Lezárult

  FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel

  NCT03723967· 2. fázis· Forrás

• Lezárult

  Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck

  NCT03818061· 2. fázis· Forrás

• Lezárult

  FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation

  NCT03584711· 2. fázis· Forrás

• Leállították

  A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)

  NCT03248492· 2. fázis· Forrás

• Leállították

  Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 Levels

  NCT03117972· 2. fázis· Forrás

• Lezárult

  PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMA

  NCT03006432· 3. fázis· Forrás

• Lezárult

  ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab

  NCT02891824· 3. fázis· Forrás

• Lezárult

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· 3. fázis· Forrás

• Lezárult

  Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation

  NCT00673335· 3. fázis· Forrás